These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2985058)

  • 1. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.
    Doebber TW; Wu MS; Robbins JC; Choy BM; Chang MN; Shen TY
    Biochem Biophys Res Commun; 1985 Mar; 127(3):799-808. PubMed ID: 2985058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
    Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X; Han GQ; Li RZ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):672-6. PubMed ID: 2983307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist.
    Handley DA; Van Valen RG; Melden MK; Flury S; Lee ML; Saunders RN
    Immunopharmacology; 1986 Aug; 12(1):11-6. PubMed ID: 3019921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist.
    Montrucchio G; Alloatti G; Mariano F; Tetta C; Emanuelli G; Camussi G
    Int J Tissue React; 1986; 8(6):497-504. PubMed ID: 3025124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes.
    Lambrecht G; Parnham MJ
    Br J Pharmacol; 1986 Feb; 87(2):287-9. PubMed ID: 3006857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.
    Hwang SB; Lam MH; Pong SS
    J Biol Chem; 1986 Jan; 261(2):532-7. PubMed ID: 3001070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
    Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M
    J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of kadsurenone analogues.
    Ponpipom MM; Bugianesi RL; Brooker DR; Yue BZ; Hwang SB; Shen TY
    J Med Chem; 1987 Jan; 30(1):136-42. PubMed ID: 3027330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists.
    Darius H; Smith JB; Lefer AM
    Int Arch Allergy Appl Immunol; 1986; 80(4):369-75. PubMed ID: 3015804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.
    Hwang SB; Lam MH; Biftu T; Beattie TR; Shen TY
    J Biol Chem; 1985 Dec; 260(29):15639-45. PubMed ID: 2999126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
    Wang J; Dunn MJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is platelet activating factor (PAF) a mediator of endotoxin shock?
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema.
    Hwang SB; Lam MH; Li CL; Shen TY
    Eur J Pharmacol; 1986 Jan; 120(1):33-41. PubMed ID: 3948914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW; Lefferts PL; Blair IA; Snapper JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
    Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
    Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats.
    Kitagawa S; Kubota Y; Yamaguchi T; Fujimura K; Binnaka T; Tani K; Ogura M; Mizuno T; Inoue K
    J Gastroenterol Hepatol; 1992; 7(5):481-5. PubMed ID: 1391729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.